NeuroBo Pharmaceuticals names new Director
7 November 2023 -

NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a US-based clinical-stage biotechnology company, announced on Monday that it has named James P Tursi, MD as its new director effective 1 November 2023.

Dr Tursi will also work as a member of the board's Nominating and Corporate Governance Committee.

Presently, Dr Tursi is an executive vice president – Global Research and Development for Endo International plc. He has worked as chief scientific officer US for Ferring Pharmaceuticals, chief medical officer and executive vice president, Research and Development for Antares Pharma Inc, chief medical officer of Aralez Pharmaceuticals Inc., chief medical officer and vice president of Clinical Research and Development for Auxilium Pharmaceuticals, Inc., and served in positions of increasing responsibility at GlaxoSmithKline plc and Procter & Gamble Pharmaceuticals. He has practiced medicine and surgery for more than 10 years and established a medical education company, I Will Pass, that assisted physicians in the process of board certification.